Exagen Announces Publication of Systematic Review Confirming Robust Real-World Performance of AVISE Lupus
Exagen reports published real-world evidence showing AVISE Lupus outperformed conventional tests and identified 25% of patients otherwise missed.
Exagen reports published real-world evidence showing AVISE Lupus outperformed conventional tests and identified 25% of patients otherwise missed.
Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.